Literature DB >> 11523081

A method for the analysis of repeated binary outcomes in randomized clinical trials with non-compliance.

T Sato1.   

Abstract

When analysing repeated binary data from randomized trials, the model-based approaches, such as generalized estimating equations, are frequently used. Such methods ignore compliance information and give the model-based intention-to-treat estimate of treatment effect. In this paper, the design-based (randomization-based) semi-parametric estimation procedure is given in the estimation of causal risk difference. The resulting risk difference estimator is interpreted as an extension of the instrumental variables estimator for a binary outcome which has the causal interpretation. Extension of the proposed method to stratified analysis is given for data from stratified randomization or meta-analysis. It yields a Mantel-Haenszel type risk difference estimator. As a special case of stratified analysis, the pattern mixture model which stratifies the data by pattern of missing data is performed. Application of the proposed method to a trial in which endpoints were the occurrences of fever over three courses is provided. The same ideas are applied to the causal risk ratio estimation. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11523081     DOI: 10.1002/sim.741

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Adjustment for Variable Adherence Under Hierarchical Structure: Instrumental Variable Modeling Through Compound Residual Inclusion.

Authors:  Tyson H Holmes; Donna M Zulman; Clete A Kushida
Journal:  Med Care       Date:  2016-01-13       Impact factor: 2.983

2.  Dose-Weighted Adjusted Mantel-Haenszel Tests for Numeric Scaled Strata in a Randomized Trial.

Authors:  Stuart A Gansky; Nancy F Cheng; Gary G Koch
Journal:  Stat Biopharm Res       Date:  2011-05-01       Impact factor: 1.452

3.  Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteria.

Authors:  Smita A Kshirsagar; Terrence F Blaschke; Lewis B Sheiner; M Krygowski; Edward P Acosta; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-09-27       Impact factor: 2.745

4.  An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials.

Authors:  Jeremy B Sussman; Rodney A Hayward
Journal:  BMJ       Date:  2010-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.